| Serial Number | 90112472 |
| Word Mark | CELLCARTA |
| Filing Date | Thursday, August 13, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, June 18, 2024 |
| Registration Number | 7422358 |
| Registration Date | Tuesday, June 18, 2024 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, January 19, 2021 |
| Goods and Services | Regulatory compliance consulting in the fields of pharmaceuticals and clinical diagnostics; Advice and consultancy on food, drug, and medical device regulatory matters; regulatory compliance consulting in the field of obtaining government authorization to market pharmaceuticals and medical device |
| Goods and Services | Genetic testing for medical purposes; Consulting services in the fields of diagnostic medical testing; Medical testing for diagnostic or treatment purposes; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; providing medical information and advice in the fields of pathology, pharmacology, and immunology; collection, organization, analysis, and reporting of medical data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices; immune monitoring, and genetic profiling for medical and diagnostic purposes |
| Goods and Services | Scientific research and development; Medical research and development; Product research and development; Biochemical research and development; Pharmaceutical research and development services; Biomedical research and development services; Design and development of biochemical, pharmaceutical, and medical assays; Scientific and pharmaceutical research in the field of biomarker discovery; Scientific research and development in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, pathology, histopathology; immune monitoring, and genetic profiling for research and development purposes; scientific research and development in the field of mass cytometry, cellular analysis, cell sorting, pathway phenotyping, and molecular surface profiling; custom design and development of chemical reagents and biochemical assays; medical laboratory services in the field of pathology; providing laboratory testing services in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, pathology, histopathology; Conducting clinical trials for others; Conducting clinical trials for others in the fields of pharmaceutical, medical, and scientific research; Consulting services for others in the field of design, planning, and implementation project management of clinical trials; Conducting research and clinical trials for others in the fields of oncology, infectious diseases, autoimmune disorders, and allergies; Consulting services in the field of clinical trial research; Providing medical and scientific research information in the field of clinical trials; Research and development in the pharmaceutical and biotechnology fields; Laboratory research services relating to pharmaceuticals; Software as a service (SAAS) services featuring software for informatics, bioinformatics; software as a service (SAAS) services featuring software for clinical trial data acquisition, validation, and analysis; Software as a service (SAAS) services featuring software for cellular analysis, cell sorting, pathway phenotyping, and molecular surface profiling; Software as a service (SAAS) services featuring software for cell cytometry; Software as a service (SAAS) services featuring software for managing information related to clinical trials |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 17, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | Sunday, February 28, 2021 |
| First Use In Commerce Date | Sunday, February 28, 2021 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 17, 2020 |
| Primary Code | 044 |
| First Use Anywhere Date | Sunday, February 28, 2021 |
| First Use In Commerce Date | Sunday, February 28, 2021 |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 17, 2020 |
| Primary Code | 045 |
| First Use Anywhere Date | Sunday, February 28, 2021 |
| First Use In Commerce Date | Sunday, February 28, 2021 |
| Party Name | CELLCARTA BIOSCIENCES INC. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | MONTREAL, QUEBEC H2X3Y7 CA |
| Party Name | CELLCARTA BIOSCIENCES INC. |
| Party Type | 21 - New Owner After Publication |
| Legal Entity Type | 03 - Corporation |
| Address | MONTREAL, QUEBEC H2X3Y7 CA |
| Party Name | Caprion Biosciences, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Montreal, Quebec H2X3Y7 CA |
| Party Name | Caprion Biosciences, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Montreal, Quebec H2X3Y7 CA |
| Event Date | Event Description |
| Monday, August 17, 2020 | NEW APPLICATION ENTERED |
| Thursday, September 17, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, December 8, 2020 | ASSIGNED TO EXAMINER |
| Wednesday, December 9, 2020 | NON-FINAL ACTION WRITTEN |
| Wednesday, December 9, 2020 | NON-FINAL ACTION E-MAILED |
| Wednesday, December 9, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, December 11, 2020 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, December 11, 2020 | EXAMINERS AMENDMENT E-MAILED |
| Friday, December 11, 2020 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, December 11, 2020 | EXAMINER'S AMENDMENT ENTERED |
| Monday, December 14, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, December 30, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, January 19, 2021 | PUBLISHED FOR OPPOSITION |
| Tuesday, January 19, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 16, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, September 16, 2021 | SOU TEAS EXTENSION RECEIVED |
| Thursday, September 16, 2021 | SOU EXTENSION 1 FILED |
| Thursday, September 16, 2021 | SOU EXTENSION 1 GRANTED |
| Saturday, September 18, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, March 15, 2022 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, March 15, 2022 | SOU EXTENSION 2 FILED |
| Tuesday, March 15, 2022 | SOU EXTENSION 2 GRANTED |
| Thursday, March 17, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, September 16, 2022 | SOU TEAS EXTENSION RECEIVED |
| Friday, September 16, 2022 | SOU EXTENSION 3 FILED |
| Friday, September 16, 2022 | SOU EXTENSION 3 GRANTED |
| Tuesday, September 20, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, February 1, 2023 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Friday, March 10, 2023 | SOU TEAS EXTENSION RECEIVED |
| Friday, March 10, 2023 | SOU EXTENSION 4 FILED |
| Friday, March 10, 2023 | SOU EXTENSION 4 GRANTED |
| Tuesday, March 14, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, September 12, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, September 12, 2023 | SOU EXTENSION 5 FILED |
| Tuesday, September 19, 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, September 19, 2023 | SOU EXTENSION 5 GRANTED |
| Wednesday, September 20, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, March 18, 2024 | USE AMENDMENT FILED |
| Monday, March 18, 2024 | TEAS STATEMENT OF USE RECEIVED |
| Tuesday, March 19, 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| Monday, May 13, 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Monday, May 13, 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Tuesday, June 18, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, June 18, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |